Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Schmidt CJ |
Acute and long-term neurochemical effects of methylenedioxymethampheta... |
NIDA Res Monogr |
1989 |
Gibb JW, Stone DM, Johnso... |
Role of dopamine in the neurotoxicity induced by amphetamines and rela... |
NIDA Res Monogr |
1989 |
Hiramatsu M, Cho AK |
Enantiomeric differences in the effects of 3,4-methylenedioxymethamphe... |
Neuropharmacology |
1990 |
Sprouse JS, Bradberry CW,... |
3,4-Methylenedioxymethamphetamine-induced release of serotonin and inh... |
Eur J Pharmacol |
1990 |
Sharkey J, McBean DE, Kel... |
Alterations in hippocampal function following repeated exposure to the... |
Psychopharmacology (... |
1991 |
Solowij N, Hall W, Lee N |
Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and thei... |
Br J Addict |
1992 |
Romano AG, Harvey JA |
MDMA enhances associative and nonassociative learning in the rabbit |
Pharmacol Biochem Be... |
1994 |
Dallakian P, Budzikiewicz... |
Detection and quantitation of amphetamine and methamphetamine: electro... |
J Anal Toxicol |
1996 |
Gartside SE, McQuade R, S... |
Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell... |
Neuropharmacology |
1997 |
Tagliaro F, Manetto G, Be... |
Simultaneous chiral separation of 3,4-methylenedioxymethamphet- amine,... |
Electrophoresis |
1998 |
Connor TJ, McNamara MG, F... |
Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces ... |
Immunopharmacology |
1998 |
Gouzoulis-Mayfrank E, The... |
Modulation of semantic priming effects by psilocybin, MDE (ecstasy) an... |
Neurology Psychiatry... |
1998 |
Hensley D, Cody JT |
Simultaneous determination of amphetamine, methamphetamine, methylened... |
J Anal Toxicol |
1999 |
Fischer HS, Zernig G, Sch... |
MDMA ('ecstasy') enhances basal acetylcholine release in brain slices ... |
Eur J Neurosci |
2000 |
Morley KC, McGregor IS |
(+/-)-3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases so... |
Eur J Pharmacol |
2000 |
Rella JG, Nelson LS, Hoff... |
7 years of 3,4-methylenedioxymethamphetamine (MDMA) toxicity |
Int J Med Toxicol |
2000 |
Esteban B, O'Shea E, Cama... |
3,4-Methylenedioxymethamphetamine induces monoamine release, but not t... |
Psychopharmacology (... |
2001 |
Bankson MB, Cunningham KA |
3,4-Methylenedioxymethamphetamine (MDMA) as a Unique Model of Serotoni... |
Journal of Pharmacol... |
2001 |
Segura M, Ortuno J, Farre... |
3,4-Dihydroxymethamphetamine (HHMA). A Major in Vivo 3,4- methylenedio... |
Chemical Research in... |
2001 |
Leshner AI |
What should the public be told about the risks of Ecstasy? |
JAMA |
2002 |
De Letter EA, Clauwaert K... |
Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA,... |
Int J Legal Med |
2002 |
De Letter EA, Clauwaert K... |
Post-mortem redistribution of 3,4-methylenedioxymethamphetamine MDMA, ... |
Int J Legal Med |
2002 |
Clemens KJ, Van Nieuwenhu... |
MDMA ('ecstasy'), methamphetamine and their combination: long-term cha... |
Psychopharmacology (... |
2004 |
Quate L, McBean DE, Ritch... |
Acute methylenedioxymethamphetamine administration: effects on local c... |
Psychopharmacology (... |
2004 |
Amstrong BD, Paik E, Chhi... |
POTENTIATION OF @L)-3,4=METHYLENEDIOXYMETHAMPHETAMINE (MDMA)-INDUCED T... |
Neuroscience Researc... |
2004 |
Rogers G, Elston J, Garsi... |
The harmful health effects of recreational ecstasy: a systematic revie... |
Health Technol Asses... |
2009 |
Ambrose JB, Bennett HD, L... |
Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingest... |
Neurologist |
2010 |
Parrott AC |
Residual neurocognitive features of ecstasy use: a re-interpretation o... |
Addiction |
2011 |
Benzer TI, Nejad SH, Floo... |
Case records of the Massachusetts General Hospital Case 40-2013A 36-ye... |
N Engl J Med |
2013 |
O'Connor AD, Padilla-Jone... |
Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity: a Comparison... |
J Med Toxicol |
2015 |